BAY86-5046 (Betaseron), Non Interventional Studies

Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis

NCT00206635 ·Status: COMPLETED

Prospective, Multicenter Non Interventional Study to Evaluate Adherence to Betaferon Over a 2 Years Period

NCT01076595 ·Status: COMPLETED

BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon® by Using Elements of the BetaPlus Program

NCT01233245 ·Status: COMPLETED

Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot Study

NCT03134573 ·Status: COMPLETED

BEYOND Pilot Study

NCT00893217 ·Status: COMPLETED ·Phase: PHASE2

BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose

NCT00459667 ·Status: COMPLETED ·Phase: PHASE3

Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-remitting Multiple Sclerosis

NCT00235989 ·Status: COMPLETED ·Phase: PHASE2

Physical Disability in Patients Treated With Betaferon

NCT00873340 ·Status: COMPLETED

Evaluation of Risk Factors for Early Termination of Injection Treatment With Betaferon in Patients Suffering From Multiple Sclerosis

NCT01184833 ·Status: COMPLETED

BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment) and BENEFIT Follow-up Study

NCT00185211 ·Status: COMPLETED ·Phase: PHASE3

US PROmyBETAapp2.0: A Study to Learn More About the Medication Usage and Patient Reported Outcomes Via the myBETAapp in Medical Care of Patients With Multiple Sclerosis Treated With BETASERON Using BETACONNECT Autoinjector

NCT04356339 ·Status: COMPLETED

Injection Management With Betaferon: Influence on Adherence, Patients Satisfaction and Health Related Outcomes (BETAPATH)

NCT00902135 ·Status: COMPLETED

Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial.

NCT01031459 ·Status: COMPLETED

BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients

NCT00099502 ·Status: COMPLETED ·Phase: PHASE3

Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment

NCT00787657 ·Status: COMPLETED

BENEFIT Extension Study

NCT00544037 ·Status: COMPLETED

China Betaferon Adherence, Coping and Nurse Support Study

NCT01436838 ·Status: COMPLETED

Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis

NCT01158183 ·Status: COMPLETED

RNF and Betaseron® Tolerability Study

NCT00428584 ·Status: COMPLETED ·Phase: PHASE3

Betaferon Use in Children and Adolescents With Multiple Sclerosis

NCT03577977 ·Status: COMPLETED

Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif

NCT00317941 ·Status: COMPLETED ·Phase: PHASE4

PROmyBETAappGame: a Study to Learn More About the Medication Usage & Patient Reported Outcomes Via the myBETAapp and to Find Out More About the Usage of Game Principles and Game Design Elements (Gamification) in Medical Care of Patients With Multiple Sclerosis Treated With Betaferon

NCT03808142 ·Status: COMPLETED

Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectors

NCT01235455 ·Status: COMPLETED

Depression and Fatigue in MS Patients Treated With Betaferon.

NCT01354665 ·Status: COMPLETED

Study Evaluating Betaferons Safety and Tolerability In Pediatric Patients With Multiple Sclerosis

NCT00963833 ·Status: COMPLETED